Bilateral versus Single Internal Thoracic Artery Grafting in Dialysis Patients with Multivessel Disease
Background: The purpose of our study was to compare mortality in dialysis patients undergoing bilateral internal thoracic artery (BITA) or single internal thoracic artery (SITA) grafting and to quantify the magnitude of the BITA grafting benefit for survival.
Methods: Between January 2002 and December 2008, 656 consecutive patients underwent isolated coronary artery bypass grafting (99.1% by an off-pump technique). Fifty-six of these patients with chronic dialysis and multivessel disease were retrospectively compared with respect to surgical technique: BITA (n = 32) or SITA (n = 23) grafting. End points were all-cause and cardiovascular mortality (mean follow-up duration, 2.5 years). In an attempt to minimize the selection bias, we created propensity scores based on 13 preoperative factors that would affect the surgeon's decision about operative strategy; these factors were used for regression adjustment (C statistic, 0.914).
Results: There were no significant differences between the 2 groups with respect to age, sex, left ventricular ejection fraction, prevalence of diabetes mellitus and peripheral arterial disease, and logistic EuroSCORE. All patients under-went revascularization with the off-pump technique, with no conversion to cardiopulmonary bypass. All arterial conduits were harvested with a skeletonization technique in all cases. Except for 1 patient who received a SITA, internal thoracic arteries were used as in situ grafts in both groups. Complete revascularization was achieved in all patients. The 1-, 3-, and 5-year survival rates free from all-cause mortality for BITA grafting versus SITA grafting were 94% versus 73%, 72% versus 42%, and 52% versus 28%, respectively (P = .01, logrank test). For survival free from cardiovascular mortality, the respective rates were 100% versus 90%, 80% versus 77%, and 80% versus 58% (P = .06). After propensity score adjustment, BITA grafting was significantly associated with lower risks for all-cause mortality (hazard ratio, 0.27; 95% confidence interval, 0.09-0.81; P = .02) and cardiovascular mortality (hazard ratio, 0.20; 95% confidence interval, 0.04-0.93; P = .04).
Conclusion: In situ skeletonized BITA grafting provides better long-term survival in dialysis patients with multivessel disease.
Asai T, Tabata S. 2002. Skeletonization of the right gastroepiploic artery using an ultrasonic scalpel. Ann Thorac Surg 74:1715-7.nAsai T. 2006. Technique and results for skeletonized GEA using the Harmonic Scalpel in combination with other arterial grafts in off-pump coronary artery bypass surgery. In: He G-W, ed. Arterial grafting for coronary artery bypass surgery. 2nd ed. Berlin: Springer-Verlag. p 196-200.nBeckermann J, Van Camp J, Li S, Wahl SK, Collins A, Herzog CA. 2006. On-pump versus off-pump coronary surgery outcomes in patients requiring dialysis: perspectives from a single center and the United States experience. J Thorac Cardiovasc Surg 131:1261-6.nBerreklouw E, Rademakers PPC, Koster JM, van Leur L, van der Wielen BJ, Westers P. 2001. Better ischemic event-free survival after two internal thoracic artery grafts: 13 years of follow-up. Ann Thorac Surg 72:1535-41.nBlakeman BP, Sullivan HJ, Foy BK, Sobotka PA, Pifarre R. 1990. Internal mammary artery revascularization in the patient on long-term renal dialysis. Ann Thorac Surg 50:776-8.nDacey LJ, Lui JY, Braxton JH, et al. 2002. Long-term survival of dialysis patients after coronary bypass grafting. Ann Thorac Surg 74:458-63.nDe Paulis R, de Notaris S, Scaffa R, et al. 2005. The effect of bilateral internal thoracic artery harvesting on superficial and deep sternal infection: the role of skeletonization. J Thorac Cardiovasc Surg 129:536-43.nDewey TM, Herbert MA, Prince SL, et al. 2006. Does coronary artery bypass graft surgery improve survival among patients with end-stage renal disease? Ann Thorac Surg 81:591-8.nEndo M, Nishida H, Tomizawa Y, Kasanuki H. 2001. Benefit of bilateral over single internal mammary artery grafts for multiple coronary artery bypass grafting. Circulation 104:2164-70.nFranga DL, Kratz JM, Crumbley AJ, Zellner JL, Stroud MR, Crawford FA. 2000. Early and long-term results of coronary artery bypass grafting in dialysis patients. Ann Thorac Surg 70:813-9.nHigami T, Kozawa S, Asada T, Shida T, Ogawa K. 2000. Skeletonization and harvest of the internal thoracic artery with an ultrasonic scalpel. Ann Thorac Surg 70:307-8.nHigami T, Yamashita T, Nohara H, Iwahashi K, Shiga T, Ogawa K. 2001. Early results of coronary grafting using ultrasonically skeletonized internal thoracic arteries. Ann Thorac Surg 71:1224-8.nKai M, Okabayashi H, Hanyu M, et al. 2007. Long-term results of bilateral internal thoracic artery grafting in dialysis patients. Ann Thorac Surg 83:1666-71.nKramer A, Mastsa A, Paz Y, et al. 2000. Bilateral skeletonized internal thoracic artery grafting in 303 patients seventy years and older. J Thorac Cardiovasc Surg 120:290-7.nLegare JF, Buth KJ, Sullivan JA, Hirsch GM. 2004. Composite arterial grafts versus conventional grafting for coronary artery bypass grafting. J Thorac Cardiovasc Surg 127:160-6.nLytle BW, Blackstone EH, Sabik JF, Houghtaling P, Loop FP, Cosgrove DM. 2004. The effect of bilateral internal thoracic artery grafting on survival during 20 postoperative years. Ann Thorac Surg 78:2005-14.nMatsa M, Paz Y, Gurevitch J, et al. 2001. Bilateral skeletonized internal thoracic artery grafts in patients with diabetes. J Thorac Cardiovasc Surg 121:668-74.nNakano J, Okabayashi H, Hanyu M, et al. 2008. Risk factors for wound infection after off-pump coronary artery bypass grafting: should bilateral internal thoracic arteries be harvested in patients with diabetes? J Thorac Cardiovasc Surg 135:540-5.nPeterson MD, Borger MA, Rao V, Peniston CM, Feindel CM. 2003. Skeletonization of bilateral internal thoracic artery grafts lowers the risk of sternal infection in patients with diabetes. J Thorac Cardiovasc Surg 126:1314-9.nPick AW, Orszulak TA, Anderson BJ, Schaff HV. 1997. Single versus bilateral internal mammary artery grafts: 10-year outcome analysis. Ann Thorac Surg 64:599-605.nSchmidt SE, Jones JW, Thornby JI, Miller CC, Beall SC Jr. 1997. Improved survival with multiple left-sided bilateral internal thoracic artery grafts. Ann Thorac Surg 64:9-15.nTaggart DP, D'Amico R, Altman DG. 2001. Effect of arterial revascularisation on survival: a systematic review of studies comparing bilateral and single internal mammary arteries. Lancet 358:870-5.nTector AJ, McDonald ML, Kress DC, Downey FX, Schmahl TM. 2001. Purely internal thoracic artery grafts: outcomes. Ann Thorac Surg 72:450-5.nUra M, Sakata R, Nakayama Y, Arai Y, Kitaoka M, Fukui H. 2001. The impact of chronic renal failure on atherosclerosis of the internal thoracic arteries. Ann Thorac Surg 71:148-51.n
How to Cite
Author Disclosure & Copyright Transfer Agreement
In order to publish the original work of another person(s), The Heart Surgery Forum® must receive an acknowledgment of the Author Agreement and Copyright Transfer Statement transferring to Forum Multimedia Publishing, L.L.C., a subsidiary of Carden Jennings Publishing Co., Ltd. the exclusive rights to print and distribute the author(s) work in all media forms. Failure to check Copyright Transfer agreement box below will delay publication of the manuscript.
A current form follows:
The author(s) hereby transfer(s), assign(s), or otherwise convey(s) all copyright ownership of the manuscript submitted to Forum Multimedia Publishing, LLC (Publisher). The copyright transfer covers the exclusive rights to reproduce and distribute the article and the material contained therein throughout the world in all languages and in all media of expression now known or later developed, including but not limited to reprints, photographic reproduction, microfilm, electronic data processing (including programming, storage, and transmission to other electronic data record(s), or any other reproductions of similar nature), and translations.
However, Publisher grants back to the author(s) the following:
- The right to make and distribute copies of all or part of this work for use of the author(s) in teaching;
- The right to use, after publication in The Heart Surgery Forum, all or part of the material from this work in a book by the author(s), or in a collection of work by the author(s);
- The royalty-free right to make copies of this work for internal distribution within the institution/company that employs the author(s) subject to the provisions below for a work-made-for-hire;
- The right to use figures and tables from this work, and up to 250 words of text, for any purpose;
- The right to make oral presentations of material from this work.
Publisher reserves the right to grant or refuse permission to third parties to republish all or part of the article or translations thereof. To republish, such third parties must obtain written permission from the Publisher. (This is in accordance with the Copyright Statute, United States Code, Title 17. Exception: If all authors were bona fide officers or employees of the U.S. Government at the time the paper was prepared, the work is a “work of the US Government” (prepared by an officer or employee of the US Government as part of official duties), and therefore is not subject to US copyright; such exception should be indicated on signature lines. If this work was prepared under US Government contract or grant, the US Government may reproduce, royalty-free, all or portions of this work and may authorize others to do so, for official US Government purposes only, if the US Government contract or grant so requires.
I have participated in the conception and design of this work and in the writing of the manuscript and take public responsibility for it. Neither this manuscript nor one with substantially similar content under my authorship has been published, has been submitted for publication elsewhere, or will be submitted for publication elsewhere while under consideration by The Heart Surgery Forum, except as described in an attachment. I have reviewed this manuscript (original version) and approve its submission. If I am listed above as corresponding author, I will provide all authors with information regarding this manuscript and will obtain their approval before submitting any revision. I attest to the validity, accuracy, and legitimacy of the content of the manuscript and understand that Publisher assumes no responsibility for the validity, accuracy, and legitimacy of its content. I warrant that this manuscript is original with me and that I have full power to make this Agreement. I warrant that it contains no matter that is libelous or otherwise unlawful or that invades individual privacy or infringes any copyright or other proprietary right. I agree to indemnify and hold Publisher harmless of and from any claim made against Publisher that relates to or arises out of the publication of the manuscript and agree that this indemnification shall include payment of all costs and expenses relating to the defense of any such claim, including all reasonable attorney’s fees.
I warrant that I have no financial interest in the drugs, devices, or procedures described in the manuscript (except as disclosed in the attached statement).
I state that the institutional Human Subjects Committee and/or the Ethics Committee approved the clinical protocol reported in this manuscript for the use of experimental techniques, drugs, or devices in human subjects and appropriate informed consent documents were utilized.
Furthermore, I state that any and all animals used for experimental purposes received humane care in USDA registered facilities in compliance with the “Principles of Laboratory Animal Care” formulated by the National Society for Medical Research and the “Guide for the Care and Use of Laboratory Animals” prepared by the Institute of Laboratory Animal Resources and published by the National Institutes of Health (NIH Publication No. 85-23, revised 1985).